ECSP045083A - Nueva enfermedad bacteriana de las aves de corral - Google Patents

Nueva enfermedad bacteriana de las aves de corral

Info

Publication number
ECSP045083A
ECSP045083A EC2004005083A ECSP045083A ECSP045083A EC SP045083 A ECSP045083 A EC SP045083A EC 2004005083 A EC2004005083 A EC 2004005083A EC SP045083 A ECSP045083 A EC SP045083A EC SP045083 A ECSP045083 A EC SP045083A
Authority
EC
Ecuador
Prior art keywords
bacterial disease
new bacterial
mannheimia haemolytica
pasteurella trehalosi
corral
Prior art date
Application number
EC2004005083A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP045083A publication Critical patent/ECSP045083A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/295Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)

Abstract

La presente pertenece al campo de la salud animal y en particular al agente causativo de una nueva enfermedad bacterial de aves de corral, Pasteurella trehalosi y / o Mannheimia haemolytica. La invención provee dicha bacteria Pasteurella trehalosi y / o Mannheimia haemolytica, vacuna que comprende Pasteurella trehalosi y / o Mannheimia haemolytica inactivada, y un método de inmunización para prevenir la enfermedad en la gallina.
EC2004005083A 2001-10-26 2004-04-23 Nueva enfermedad bacteriana de las aves de corral ECSP045083A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10152307A DE10152307A1 (de) 2001-10-26 2001-10-26 Neue bakterielle Geflügelkrankheit

Publications (1)

Publication Number Publication Date
ECSP045083A true ECSP045083A (es) 2004-08-27

Family

ID=7703460

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005083A ECSP045083A (es) 2001-10-26 2004-04-23 Nueva enfermedad bacteriana de las aves de corral

Country Status (32)

Country Link
US (3) US7794735B2 (es)
EP (2) EP1942181A1 (es)
JP (2) JP4447319B2 (es)
KR (2) KR101024887B1 (es)
CN (1) CN100471945C (es)
AR (3) AR037020A1 (es)
AT (1) ATE391767T1 (es)
AU (1) AU2002363173B2 (es)
BR (1) BR0213538A (es)
CA (1) CA2462652A1 (es)
CO (1) CO5580796A2 (es)
CY (1) CY1108178T1 (es)
DE (2) DE10152307A1 (es)
DK (1) DK1442114T3 (es)
EC (1) ECSP045083A (es)
ES (1) ES2304466T3 (es)
HK (1) HK1073862A1 (es)
HR (1) HRP20040366B1 (es)
HU (1) HU228692B1 (es)
IL (1) IL161223A0 (es)
MA (1) MA26293A1 (es)
MX (1) MXPA04003941A (es)
MY (1) MY138203A (es)
NO (1) NO333635B1 (es)
NZ (1) NZ532805A (es)
PL (1) PL206589B1 (es)
PT (1) PT1442114E (es)
RU (4) RU2430967C2 (es)
SI (1) SI1442114T1 (es)
UA (2) UA96948C2 (es)
WO (1) WO2003037367A2 (es)
ZA (1) ZA200402499B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10152307A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
KR20130027448A (ko) * 2009-10-09 2013-03-15 코벤하븐스 유니버시테트 갈리박테리움 아나티스로부터의 세포용해 rtx-독소
CN102406936A (zh) * 2011-11-22 2012-04-11 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗佐剂
CN102380092A (zh) * 2011-11-22 2012-03-21 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗
EP2976102B1 (en) 2013-03-18 2019-12-11 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
RU2563885C1 (ru) * 2014-06-03 2015-09-27 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ определения антител к бактериальным антигенам
CN104491856A (zh) * 2014-12-07 2015-04-08 青岛易邦生物工程有限公司 一种禽肺病毒病灭活疫苗的生产方法
CN108728558A (zh) * 2018-05-31 2018-11-02 广西壮族自治区兽医研究所 一种快速检测溶血性曼氏杆菌的pcr扩增引物及其应用
CN111621450B (zh) * 2020-07-10 2022-07-05 青岛易邦生物工程有限公司 一种鸭源鸡杆菌及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855894A (en) 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
EP0625190B1 (en) * 1992-10-14 1996-12-27 Akzo Nobel N.V. New bacterium causing poultry disease and vaccine derived thereof
US5587305A (en) 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
RU94023126A (ru) * 1994-06-16 1997-04-10 Всероссийский научно-исследовательский институт экспериментальной ветеринарии им.Я.Р.Коваленко Вакцина против пастереллеза свиней
RU2103355C1 (ru) * 1995-11-23 1998-01-27 Государственное Федеральное предприятие Государственный научный центр прикладной микробиологии Способ получения аттенуированных иммуногенных штаммов pasteurella multocida
FR2760640B1 (fr) * 1997-03-17 1999-05-28 Vetoquinol Sa Utilisation d'une souche de pasteurella haemolytica serotype a6 pour la preparation d'un vaccin contre la pasteurellose bovine due a pasteurella haemolytica
WO2001044289A2 (en) * 1999-12-17 2001-06-21 University Of Guelph Office Of The Vice President Of Research Modified leukotoxin gene and protein
US7521060B2 (en) 2001-10-26 2009-04-21 Boehringer Ingelheim Vetmedica S.A. De C.V. Pathogen for bacterial poultry disease
DE10152307A1 (de) 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit

Also Published As

Publication number Publication date
ZA200402499B (en) 2005-06-08
BR0213538A (pt) 2004-10-19
RU2430967C2 (ru) 2011-10-10
NZ532805A (en) 2008-04-30
UA89607C2 (ru) 2010-02-25
HUP0402098A3 (en) 2005-07-28
DE60226057D1 (de) 2008-05-21
ATE391767T1 (de) 2008-04-15
JP2005511032A (ja) 2005-04-28
EP1442114B1 (en) 2008-04-09
KR20050039688A (ko) 2005-04-29
RU2481393C2 (ru) 2013-05-10
JP2010051324A (ja) 2010-03-11
JP5087604B2 (ja) 2012-12-05
JP4447319B2 (ja) 2010-04-07
MA26293A1 (fr) 2004-09-01
WO2003037367A2 (en) 2003-05-08
KR101024887B1 (ko) 2011-03-31
CN1575334A (zh) 2005-02-02
AR037020A1 (es) 2004-10-20
US20100104594A1 (en) 2010-04-29
PL369963A1 (en) 2005-05-02
SI1442114T1 (sl) 2008-08-31
MXPA04003941A (es) 2004-11-29
US20110212132A1 (en) 2011-09-01
US20090181055A1 (en) 2009-07-16
MY138203A (en) 2009-05-29
DE60226057T2 (de) 2009-05-14
AR067732A2 (es) 2009-10-21
IL161223A0 (en) 2004-09-27
HU228692B1 (en) 2013-05-28
AR073482A2 (es) 2010-11-10
CA2462652A1 (en) 2003-05-08
CO5580796A2 (es) 2005-11-30
DE10152307A1 (de) 2003-05-08
RU2007148219A (ru) 2009-07-10
KR20090083941A (ko) 2009-08-04
RU2007129099A (ru) 2009-02-10
RU2334792C2 (ru) 2008-09-27
HRP20040366A2 (en) 2005-04-30
ES2304466T3 (es) 2008-10-16
US7794735B2 (en) 2010-09-14
WO2003037367A3 (en) 2003-10-09
EP1942181A1 (en) 2008-07-09
DK1442114T3 (da) 2008-06-09
NO20041675L (no) 2004-04-23
PL206589B1 (pl) 2010-08-31
US7964197B2 (en) 2011-06-21
HRP20040366B1 (en) 2012-05-31
HUP0402098A2 (hu) 2005-02-28
PT1442114E (pt) 2008-05-20
EP1442114A2 (en) 2004-08-04
CN100471945C (zh) 2009-03-25
UA96948C2 (ru) 2011-12-26
KR100954175B1 (ko) 2010-04-20
RU2456343C2 (ru) 2012-07-20
RU2008136404A (ru) 2010-03-20
RU2004116134A (ru) 2005-05-10
AU2002363173B2 (en) 2007-09-20
NO333635B1 (no) 2013-07-29
CY1108178T1 (el) 2014-02-12
HK1073862A1 (en) 2005-10-21

Similar Documents

Publication Publication Date Title
AR073482A2 (es) Enfermedad bacteriana de las aves de corral
UA81676C2 (ru) Композиция для лечения инфекций у крупного рогатого скота и свиней
ATE255419T1 (de) Für den vogelembryo geeignete multivalente impfstoffe
HUP0301634A2 (hu) Hőmérséklet-érzékeny, élő vakcina Mycoplasma hyopneumoniaera
AR052855A1 (es) Composiciones para el cuidado bucal que contienen un extrato de eucalyptus
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
CY1105309T1 (el) Συμπλεγμα εμβολιου που προοριζεται για προληψη και θepαπεια των λεϊσμανιασεων
BRPI0413083A (pt) métodos para tratar inflamação e doenças associadas com inflamação com uma estatina e éter
DE60218473D1 (de) Verfahren zur herstellung polyvalenter bakteriophagenpräparationen zur behandlung bakterieller infektionen
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
HUP0401077A2 (hu) Mycoplasma bovis fertőzési modell, valamint eljárások M. bovis bejuttatására és tüdőgyulladásos tüdőléziók indukálására
AR009650A1 (es) Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna.
PT894500E (pt) Vacina para streptococcus equi
MXPA05012219A (es) Vacuna aviar combinada contra e. coli y salmonella.
ATE359815T1 (de) Streptococcus-phocae-vakzine
BR0007966A (pt) Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
HUP0101347A2 (hu) Eljárás parazitafertőzés kezelésére
DE60114778D1 (de) Behandlung von infektionen in tieren
ATE495757T1 (de) Attenuierte bakterielle lebendvakzine
AR035202A1 (es) Vacuna viva termo-sensible contra mycoplasma hyopneumoniae
TH78298A (th) โรคสัตว์ปีกชนิดใหม่ที่เกิดจากแบคทีเรีย
TH95334A (th) การใช้ของวัคซีนสำหรับการรักษา/การป้องกันของการแพร่เชื้อของจุลชีพก่อโรค